Please provide your email address to receive an email when new articles are posted on . LONDON — In patients with ACS undergoing PCI, rates of major adverse cardiac events and net adverse clinical ...
A chart review was performed for all patients who received heparin from July 1, 1999, through February 28, 2000, in an acute care hospital in Athens, Georgia. Data collected included age, sex, height, ...
This was a single-center, observational cohort study conducted at an 852-bed academic medical center. The study involved a review of electronic and paper medical records of patients who received ...
B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. Based on the new United States Pharmacopeia (USP) standards for heparin products released ...
A before-and-after comparison following the exclusion of heparin from continuous infusions through PICCs placed by a designated team. Duration of use was assessed during epochs immediately preceding ...
Correctly diagnosing heparin resistance in patients on extracorporeal membrane oxygenation (ECMO) is challenging. In patients with sepsis, the differential diagnosis for heparin resistance is large, ...
A pooled analysis of individual patient data from the major bivalirudin versus unfractionated heparin trials concludes that preprocedural bivalirudin could be considered the agent of choice in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results